2026 UVA Medical Oncology Update

This conference will contain multiple simulated cases to reinforce learning points in an optimized format for busy community oncologists. The cases presented in this conference are those most frequently encountered by community providers, highlighting key concepts to help providers follow best practices.

Friday, November 6, 2026, 7:00 AM - 5:05 PM ET, The Forum Hotel, Charlottesville, VA

1. Describe key concepts in managing oligometastatic prostate cancer
2. Discuss intensification of androgen deprivation therapy in metastatic prostate cancer
3. Summarize recent updates in perioperative treatment for muscle-invasive bladder cancer
4. Evaluate the clinical role of ctDNA in the management of urothelial cancer
5. Identify indications for novel therapies, including oral targeted therapies and antibody drug conjugates, in the treatment of NSCLC and SCLC
6. Recognize indications for bi-specific antibody therapies in the treatment of NSCLC and SCLC
7. Apply best practices for using biomarkers to optimize therapy selection in metastatic esophago-gastric cancers
8. Identify optimal neuroendocrine patients for upfront PRRT
9. Implement management strategies for new KRAS-directed therapies and associated toxicities in pancreatic cancer
10. Integrate results from the NADINA trial to select appropriate patients with stage III melanoma for neoadjuvant nivolumab and ipilimumab
11. Apply current evidence on immunotherapy combinations and TIL therapy to optimize treatment selection for patients with advanced melanoma, including those refractory to prior immune checkpoint inhibitors and/or BRAF/MEK inhibitors
12. Sequence FDA approved drugs for advanced breast cancer using genomic predictor tools and patient parameters to personalize therapies
13. Outline, apply, and interpret ctDNA tools for early and late-stage breast cancer, select high-risk early-stage patients for ctDNA surveillance, and choose ctDNA-guided therapies for late-stage disease
14. Implement screening procedures and treatment paradigms for novel toxicities of emerging FDA approved drugs for the treatment of early and advanced breast cancers

AMA PRA Category 1 Credits™ (7.00 hours), ACPE (7.00 hours), ANCC Contact Hours (7.00 hours), Hours of Participation (7.00 hours), IPCE (7.00 hours)

Participant Rates:	Thru 9/7/26	9/8/26- 10/24/26
Physicians	$100	$125
Other Healthcare Professionals	$50	$75
Industry Employees	$500	$500

*UVA Faculty & Staff: use Discount Code MEDONC26 for complimentary registration using your uva email address. No refunds will be issued.*

Riverside Faculty & Staff: use Discount Code MEDONC26RV for 50% off registration using your Riverside email address. No refunds will be issued.*

Cancellation Policy

Cancellation requests received in writing no less than 30 days before the course will be refunded, less a 20% administrative fee. No refunds will be provided for cancellation requests received within 30 days or for registration fees of less than $50.  Please send cancellation requests [email protected].

 

UVA Health Continuing Education reserves the right to cancel CE activities if necessary.  In this case, the entire registration fee will be refunded.  All other expenses incurred in conjunction with this CE activity are the sole responsibility of the participant.

Accessibility Statement
 
UVACE is committed to ensuring equal access to educational opportunities for individuals with disabilities, in compliance with the Americans with Disabilities Act of 1990 (ADA), as amended, and Section 504 of the Rehabilitation Act of 1973 (Section 504), as well as other applicable state and local laws and University policy. Individuals with disabilities are entitled to reasonable accommodations to ensure their participation in courses. Please note that some of the course venues at UVA are registered historic properties and may not be fully ADA accessible. If you have needs that require special accommodation, including dietary concerns, please email [email protected].  All requests must be received 30 days prior to the course start date.

In support of improving patient care, UVA Health Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

UVA Health Continuing Education designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits.^TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

UVA Health Continuing Education awards up to 7.0 contact hour(s) for nurses who participate in this educational activity and complete the post activity evaluation

Hours of Participation

UVA Health Continuing Education awards 7.0 hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)^TM or ANCC contact hours) to a participant who successfully completes this educational activity. UVA Health Continuing Education maintains a record of participation for six (6) years.

Pharmacists*

UVA Health Continuing Education has been authorized by the Accreditation Council for Pharmacy Education (ACPE) to award ACPE credit for activities planned in accordance with ACPE Criteria. This knowledge-based activity is designated for 7.0 ACPE credit hours.

*DOB and NABP are required for reporting APCE credit

You are not logged in.

Please click the button below to login or create a new account before continuing.

Kimpton The Forum Hotel

540 Massie Rd, Charlottesville, VA 22903

Reserve rooms no later than Friday, October 6, 2026 at the Forum Kimpton Hotel in Charlottesville. Call the hotel at (434) 365-2600 group name: 2026 UVA Medical Oncology Update or click this link to receive the special group rate of $229+tax/fees.

Any reservations or changes made past the cutoff date cannot be guaranteed but will be accepted based on availability.

Mitigation of Relevant Financial Relationships

Thank you to the conference co-directors, Dr. Robert Dreicer, Dr. Richard Hall, and Dr. Ryan Gentzler for their efforts in creating this engaging education event.

To read a faculty biography, select the name below.

UVA Health Continuing Education adheres to the Joint Accreditation Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

To view financial disclosures, select the faculty name below. 

Friday, November 6, 2026

Exhibit Spaces are LIMITED and given on a first come, first serve basis. To reserve your spot, please select EXHIBIT AT THIS EVENT button below. 

Copy of Exhibit Opportunities

Copy of Promotion and Exhibit Agreement 

W-9

Please note: Exhibit registration does NOT include access to the education space (see above Exhibit Opportunities letter for details of what is included in exhibit registration). If you want to attend the sessions and/or claim personal continuing education credit, you will also need to register as an "Industry Employee" attendee on the "Register" tab for $500.

Exhibit at this Event